HC Wainwright Reaffirms “Buy” Rating for Aptose Biosciences (NASDAQ:APTO)

Aptose Biosciences (NASDAQ:APTO – Get Free Report) (TSE:APS)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They currently have a $2.00 target price on the biotechnology company’s stock. Separately, StockNews.com started coverage on Aptose Biosciences in a report on Sunday, February 9th. They […]